UNSPSC 51411903: Emopamil

This classification denotes a vasodilating agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M514041RF7. European Medicines Agency schedules Emopamil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06510MIG. Emopamil generally arises in the molecular formula C23H30N2. The term EMOPAMIL is an International Non-Proprietary Name or INN. EMOPAMIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule emopamil under HS 29269095 and SITC 51484. As of Q4 2014, EMOPAMIL remains the US FDA Preferred Term for this commodity. Emopamil bears US NLM identifiers UMLS ID C0059080 and NCI Concept Code C74417. SMILES: N(CCCC(C(C)C)(c1ccccc1)C#N)(CCc1ccccc1)C.

UNSPSC 51411903 Emopamil is a Commodity code covering pharmaceutical active ingredients and formulations used in emergency medical care. State and local governments procure under this code primarily to stock advanced life support medications for fire rescue and emergency medical services operations. The scope includes specific pharmaceutical line items such as epinephrine, labetalol, adenosine, and diltiazem — critical drugs administered in acute cardiac and hemodynamic emergencies. Purchasing departments issue these solicitations on behalf of fire rescue services and emergency medical divisions within municipal governments. Vendors must meet pharmaceutical supply chain requirements including expiration-date guarantees (typically nine months or longer from acceptance), rapid delivery (often within ten calendar days of order), product warranties against defects, and compliance with OSHA Hazard Communication Standards and accessibility documentation requirements.

The City of Tampa's Purchasing Department posted an IFB in April 2026 (Solicitation 26P00188, due April 8, 2026) for Advanced Life Support Medications to supply Tampa Fire Rescue in Hillsborough County, Florida, with an estimated contract value of $40,000.00. The bid solicited four specific medication line items totaling approximately 3,530 units across labetalol, epinephrine, adenosine, and diltiazem, with delivery to Tampa and a one-year initial term plus two optional one-year renewals. The City designated this opportunity as a sheltered market for Small Local Business Enterprises with a 5 percent bid discount, not to exceed $10,000. Beyond this single recent opportunity, the source provides no additional state or local activity under this code; geographic concentration and issuing-body patterns cannot be characterized from available data.